About Simon Tomlinson
Form D filings for Duet Therapeutics in 2023 list Simon Tomlinson as chief executive officer and director.
Simon Tomlinson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Simon Tomlinson in the role, so the role may have started earlier or lasted longer.